Table I.
Clinicopathologic variables of breast cancer patient cohort.
| Variables | Number of patients | % |
|---|---|---|
| Age | ||
| <50 years | 31 | 28.2 |
| ≥50 years | 79 | 71.8 |
| Tumor size | ||
| <2 cm | 46 | 41.8 |
| ≥2 cm | 64 | 58.2 |
| Tumor stage | ||
| T1 | 34 | 30.9 |
| T2 | 76 | 69.1 |
| Histologic grade | ||
| G1 | 5 | 4.5 |
| G2 | 86 | 78.2 |
| G3 | 19 | 17.3 |
| Node status | ||
| Negative | 68 | 61.8 |
| Positive | 42 | 38.2 |
| Histologic type | ||
| Ductal | 93 | 84.5 |
| Others | 17 | 15.5 |
| Molecular subtypes | ||
| Luminal | 30 | 27.3 |
| Others | 80 | 72.7 |
| Her2 status | ||
| Negative | 91 | 82.7 |
| Positive | 19 | 17.3 |
| CTC | ||
| Negative | 47 | 42.7 |
| Positive | 63 | 57.3 |
| Tif1γ status | ||
| Negative | 58 | 52.7 |
| Positive | 52 | 47.3 |
Her2, human epidermal growth factor receptor 2; CTCs, circulating tumor cells; Tif1γ, transcription intermediary factor 1γ.